CAT
Caterpillar Inc.
CAT has lower modeled downside risk, despite its lower overall score.
MIR
Mirion Technologies, Inc.
MIR has a slight edge over CAT overall, supported by stronger valuation.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
MIR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
MIR's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
MIR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 29x | $17.95 | — |
| Current | 150x | $17.95 | — |
| Cheap | 158x | $18.93 | +5.5% |
| Fair | 186x | $22.33 | +24% |
| Expensive | 506x | $60.75 | +238% |
Historical ranges are pointers, not guarantees.
MIR has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
MIR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for MIR, with profitability improving. However, they disagree widely on these estimates.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
MIR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.62 | +415% |
| Q3 2026 | $0.12 | 0% |
| Q2 2026 | $0.10 | +150% |
| Q1 2026 | $0.10 | +$0.15 |
| Q4 2025 | $0.11 | +$0.29 |
| Q3 2025 | $0.12 | +$0.45 |
| Q2 2025 | $0.04 | +$0.36 |
| Q1 2025 | -$0.05 | +$0.35 |
| Q4 2024 | -$0.18 | +$0.31 |
MIR has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over MIR on profitability, with a higher operating margin.
MIR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $277.8M | +25% |
| Q2 2026 | $266.8M | +20% |
| Q1 2026 | $257.6M | +28% |
| Q4 2025 | $277.4M | +9.1% |
| Q3 2025 | $223.1M | +7.9% |
| Q2 2025 | $222.9M | +7.6% |
| Q1 2025 | $202M | +4.9% |
| Q4 2024 | $254.3M | +10% |
MIR's revenue has grown year over year every quarter since mid-2022: $278M last quarter, up 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.2% | +2.9 points |
| Q2 2026 | 6.7% | +2.3 points |
| Q1 2026 | 1.4% | -2.9 points |
| Q4 2025 | 9.2% | -2.2 points |
| Q3 2025 | 3.3% | +4.1 points |
| Q2 2025 | 4.4% | +3.3 points |
| Q1 2025 | 4.3% | +6.8 points |
| Q4 2024 | 11% | +5.6 points |
MIR's operating margin was 6.2% last quarter, up 2.9 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
MIR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $47.3M | +264% |
| Q2 2026 | $48.1M | +1236% |
| Q1 2026 | $9.4M | -65% |
| Q4 2025 | $63.2M | +29% |
| Q3 2025 | $13M | +233% |
| Q2 2025 | $3.6M | -12% |
| Q1 2025 | $27.1M | +$33.9M |
| Q4 2024 | $49.1M | -11% |
MIR has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over MIR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
MIR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2.2M shares |
| 1 year | +6.7% | +17.2M shares |
| 3 years | +37% | +73.7M shares |
| 5 years | +1256% | +253M shares |
MIR has 273M diluted shares, up 6.7% from a year ago, despite $97M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $55.8M |
| Q2 2026 | $25M |
| Q1 2026 | $16M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $31M |
| Q1 2025 | $18.6M |
| Q4 2024 | $1M |
MIR spent $97M buying back its own shares over the past year, up 91% from the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over MIR on leverage, with a lower net debt burden relative to earnings.
MIR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
MIR's net debt is less than a year of its operating earnings (EBITDA).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MIR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.4 | Neutral |
| Stochastic | 78.4 | Neutral |
MIR's weekly RSI is 53 (neutral) and its Stochastic is 78 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over MIR on valuation relative to its sector.
MIR PE vs Industrials Sector
| Metric | MIR | Sector median | Relative |
|---|---|---|---|
| PE | 150x | 24x | 522% above |
| PE % | 6 | 54 | 48 pts below |
MIR is trading at 150x earnings, a 522% premium to the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
MIR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.4 | 9.6% above |
| 20 week MA | $16.1 | 11% above |
| 50 week MA | $19.1 | 5.9% below |
| 100 week MA | $19.3 | 6.9% below |
| 200 week MA | $14.6 | 23% above |
MIR has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over MIR on returns for 2026, with the stronger performance.
MIR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.98 | $10.9 | +8.7% |
| 2021 | $10.9 | $10.5 | -3.4% |
| 2022 | $10.5 | $6.49 | -38% |
| 2023 | $6.49 | $10.3 | +58% |
| 2024 | $10.3 | $17.6 | +72% |
| 2025 | $17.6 | $23.8 | +35% |
| 2026 YTD | $23.8 | $18.0 | -24% |
MIR has finished higher in four of the last six years, two of them by more than 50%. It's down 24% so far in 2026.